The Fundamentals of Combination Products

Step into the complex intersection of regulatory science for a guided tour through the fundamentals of Combination Products. We’ll explore the essential differences between a drug, a biologic, and a device. Using real-world patient scenarios, we’ll see how these components fuse into three distinct types: single-entity systems, co-packaged kits, and clinically interdependent cross-labeled solutions. The core of this course is mastering the Primary Mode of Action (PMOA). We’ll show you why this PMOA classification is the single, decisive factor that dictates the entire regulatory future of the product. You’ll come away with a strong, foundational understanding of how clear regulatory classification drives integrated oversight and ultimately guarantees the safety and success of these next-generation therapies for patients.